PLAP Antibody (8F0)
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-43019
Key Product Details
Species Reactivity
Human, Mouse
Applications
ELISA, Immunohistochemistry, Western Blot
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG1 Clone # 8F0
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
phospholipase A2-activating protein - (Uniprot# Q9Y263)
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Theoretical MW
80 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Applications for PLAP Antibody (8F0)
Application
Recommended Usage
Immunohistochemistry
1:50 - 1:500
Western Blot
1:500 - 1:2000
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
PBS (pH 7.3), 50% glycerol
Preservative
0.02% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: PLAP
Alternate Names
DOA1, FLJ12699, phospholipase A-2-activating protein, phospholipase A2-activating protein, PLAP
Gene Symbol
PLAA
Additional PLAP Products
Product Specific Notices for PLAP Antibody (8F0)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...